NCT00370994

Brief Summary

Clinically significant improvements in the percutaneous adhesiolysis patients with hypertonic neurolysis compared to those patients randomized to the control group who did not receive adhesiolysis and hypertonic saline neurolysis. Improvement will be assessed in relation to the clinical outcome measures of pain and function. Improvements among patients with adhesiolysis and hypertonic saline neurolysis and compare to control group. Compare adverse event profile in both groups

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P75+ for not_applicable low-back-pain

Timeline
Completed

Started Jan 2006

Longer than P75 for not_applicable low-back-pain

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2006

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

August 30, 2006

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 1, 2006

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2009

Completed
3.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2013

Completed
2.6 years until next milestone

Results Posted

Study results publicly available

November 23, 2015

Completed
Last Updated

March 10, 2020

Status Verified

March 1, 2020

Enrollment Period

3.9 years

First QC Date

August 30, 2006

Results QC Date

March 21, 2012

Last Update Submit

March 2, 2020

Conditions

Keywords

post-lumbar surgery syndromepercutaneous lumbar epidural adhesiolysishypertonic saline neurolysis

Outcome Measures

Primary Outcomes (1)

  • Numeric Pain Rating Score

    Numeric rating scale represented 0 with no pain and 10 with the worst pain imaginable

    3, 6, 12, 18 and 24 months post treatment.

Secondary Outcomes (1)

  • Functional Status

    3, 6, 12, 18 and 24 months post treatment.

Study Arms (2)

Caudal epidural injection

ACTIVE COMPARATOR

Caudal epidural with placement of catheter in sacral canal with injection of 5 mL of 2% preservative-free lidocaine, followed by 6 mL of 0.9% sodium chloride solution and 6 mg of non-particulate Betamethasone and 1 mL of sodium chloride solution

Procedure: Caudal epidural injection

Percutaneous adhesiolysis

ACTIVE COMPARATOR

Pecutaneous adhesiolysis and targeted placement of Racz catheter with injection of 5 mL of 2% preservative-free lidocaine, followed by 6 mL of 10% sodium chloride solution and 6 mg of non-particulate Betamethasone and 1 mL of sodium chloride solution

Procedure: Percutaneous adhesiolysis

Interventions

Caudal epidural injection with catheterization

Caudal epidural injection

Percutaneous adhesiolysis with hypertonic saline neurolysis

Percutaneous adhesiolysis

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Over 18 years of age
  • History of chronic, function limiting low back pain of at least 6 months in duration
  • Able to give voluntary, written informed consent
  • Able to understand investigational procedures and willing to return for follow-ups
  • No recent surgical procedures within last 3 months

You may not qualify if:

  • Large contained or sequestered herniation
  • Cauda Equina symptoms and/or compressive radiculopathy
  • Narcotic use of no greater than 100mg/day Hydrocodone, 60mg Methadone, or 100mg Morphine
  • Uncontrolled major depression or psychiatric disorder
  • Uncontrolled or acute medical illness
  • Chronic sever conditions that could interfere with outcome assessments
  • Women who are pregnant or lactating
  • Subjects who have participated in a clinical study with an investigational product within 30 days of enrollment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ambulatory Surgery Center

Paducah, Kentucky, 42003, United States

Location

Related Publications (3)

  • Manchikanti L, Singh V, Cash KA, Pampati V. Assessment of effectiveness of percutaneous adhesiolysis and caudal epidural injections in managing post lumbar surgery syndrome: 2-year follow-up of a randomized, controlled trial. J Pain Res. 2012;5:597-608. doi: 10.2147/JPR.S38999. Epub 2012 Dec 20.

  • Manchikanti L, Singh V, Cash KA, Pampati V, Datta S. A comparative effectiveness evaluation of percutaneous adhesiolysis and epidural steroid injections in managing lumbar post surgery syndrome: a randomized, equivalence controlled trial. Pain Physician. 2009 Nov-Dec;12(6):E355-68.

  • Manchikanti L, Cash KA, McManus CD, Pampati V, Singh V, Benyamin R. The preliminary results of a comparative effectiveness evaluation of adhesiolysis and caudal epidural injections in managing chronic low back pain secondary to spinal stenosis: a randomized, equivalence controlled trial. Pain Physician. 2009 Nov-Dec;12(6):E341-54.

Related Links

MeSH Terms

Conditions

Low Back Pain

Condition Hierarchy (Ancestors)

Back PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Limitations and Caveats

The results of this study are limited by potentially inadequate double blinding, by the lack of a placebo group.

Results Point of Contact

Title
Dr. Laxmaiah Manchikanti
Organization
Pain Management Center of Paducah

Study Officials

  • Laxmaiah Manchikanti, MD

    Ambulatory Surgery Center

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Director

Study Record Dates

First Submitted

August 30, 2006

First Posted

September 1, 2006

Study Start

January 1, 2006

Primary Completion

December 1, 2009

Study Completion

April 1, 2013

Last Updated

March 10, 2020

Results First Posted

November 23, 2015

Record last verified: 2020-03

Locations